-
ProductsOur company can produce anti-tumor, anti-fungal, antibiotics, nutrition, anesthesia, cardiovascular and cerebrovascular products such as 6 categories of series of products, the company's existing domestic products 73 product specifications and foreign products 22 product specifications.
-
NewsFrom 2019 to now, the company has attracted 38 kinds of generic drugs developed by 12 scientific research institutes such as Beijing Tongrentang Pharmaceutical Technology Development Co., Ltd. and Shanghai Rongdi Biotechnology Co., Ltd. to land in our company. After all of them are put into production, the annual output value can be increased by 1 billion and the profit can be about 0.2 billion.
Shanxi Nuocheng Pharmaceutical Co., Ltd. Renovation and Expansion of 2 × 63 Tons of Amino Acid Derivative Series and 2 × 4 Tons of Cimetidine Raw Material Drug Production Line Project (Phased) Environmental Protection Facilities Completion Publicity
Date:
2022-08-12
According to the "Decision of the State Council on Amending the Regulations on the Administration of Environmental Protection of Construction Projects" (State Council Order No. 682), and the original Ministry of Environmental Protection "On Issuing<建设项目竣工环境保护验收暂行办法>The announcement of the "(national environmental planning and environmental assessment [2017] No. 4) and the" technical specification for environmental protection acceptance of construction project completion "(HJ 792-2016), the completion date of environmental protection facilities of Shanxi nuocheng pharmaceutical co., ltd. for the project of rebuilding and expanding the production line of amino acid derivatives with an annual output of 2 × 63 tons and cimetidine bulk drug products with an annual output of 2 × 4 tons is hereby announced as follows:</建设项目竣工环境保护验收暂行办法>
According to the Decision of the State Council on Amending the Regulations on the Administration of Environmental Protection of Construction Projects (Order No. 682 of the State Council), the Announcement of the former Ministry of Environmental Protection on Issuing the Interim Measures for the Acceptance of Environmental Protection after Completion of Construction Projects (No. 4 [2017] of the State Environmental Regulation) and the Technical Specification for the Acceptance of Environmental Protection after Completion of Construction Projects (HJ 792-2016), the completion date of environmental protection facilities for the project of Shanxi Nuocheng Pharmaceutical Co., Ltd. to rebuild and expand the production line with an annual output of 2 × 63 tons of amino acid derivatives and an annual output of 2 × 4 tons of cimetidine bulk drug products is announced as follows:
Brief Description of 1. Project
Project name: Shanxi Nuocheng Pharmaceutical Co., Ltd. to expand the annual output of 2 × 63 tons of amino acid derivatives series, annual output of 2 × 4 tons of cimetidine raw material drug product production line project
Project summary: Shanxi Nuocheng Pharmaceutical Co., Ltd. rebuilds and expands the production line of amino acid derivatives with an annual output of 2 × 63 tons and cimetidine with an annual output of 2 × 4 tons. The project is located in Shanxi Nuocheng Pharmaceutical Co., Ltd. in the pharmaceutical park of Huairen Economic and Technological Development Zone. It designs and constructs the first workshop of raw materials and the second workshop of raw materials and its supporting environmental protection public auxiliary projects, it is designed to produce 120 tons of fluorenylmethoxycarbonyl-N-hydroxysuccinic acid imide ester (FMOC-OSU), 6 tons of N-fluorenylmethoxycarbonyl-tyrosine (tert-butyl ether)(Fmoc-Tyr(tBu)-OH) and 8 tons of cimetidine per year. Now the first workshop of API and its supporting environmental protection and public auxiliary facilities have been completed, so the scope of environmental protection acceptance of this stage completion is the first workshop of API and its supporting environmental protection and public auxiliary facilities, the construction scale is an annual output of 60 tons of fluorenylmethoxycarbonyl-N-hydroxysuccinic acid imide ester (FMOC-OSU), an annual output of 3 tons of N-fluorenylmethoxycarbonyl-tyrosine (tert-butyl ether)(Fmoc-Tyr(tBu)-OH) and an annual output of 4 tons of cimetidine.
On May 18, 2021, Shuozhou Administrative Examination and Approval Service Administration issued Shuo Approval Letter [2021] No. 59 to "Regarding the reconstruction and expansion of Shanxi Nuocheng Pharmaceutical Co., Ltd. with an annual output of 2 × 63 tons of amino acid derivative series and an annual output of 2 × 63 tons." 4 tons of cimetidine API production line project environmental impact report "was approved.
Publicity of completion date of 2. environmental protection facilities
The environmental protection facilities for the phased acceptance of the Project have been completed and are hereby announced.
Completion publicity time: August 12, 2022
Contact Information of 3. Construction Unit
Construction address: the project is located in the pharmaceutical park of huairen economic and technological development zone, shanxi nuocheng pharmaceutical co., ltd.
Contact: Li Jianjun
Contact Phone:13903526739
Shanxi Nuocheng Pharmaceutical Co., Ltd.
August 12, 2022
Key words:
Biopharmaceuticals
2023-07-02
Self-monitoring programme in 2023
2023-06-26
Fuze the world, a promise will be made!
Norcheng Pharmaceuticals
Copyright©2023 Shanxi Nuocheng Pharmaceutical Co., Ltd.